-+ 0.00%
-+ 0.00%
-+ 0.00%

NERVGEN PHARMA CORP - TO CONCLUDE ENROLLMENT IN PHASE 1B/2A CONNECT SCI SUBACUTE TETRAPLEGIA AND UNBLIND DATA

Reuters·04/07/2026 11:30:00

Please log in to view news